How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players

Virology

Volumn 234, Issue 2, 1997, Pages 179-185

  Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RNA VIRUS; VIRUS INFECTION;

ANIMALIA; CHORIOMENINGITIS VIRUS; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RNA VIRUSES;

EID: 0030876638     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8674     Document Type: Article

References (67)

1. Aebischer T., Moskophidis D., Rohrer U. H., Zinkernagel R. H., Hengartner R. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 88:1991;11047-11051.
2. Ahn K., Meyer T. H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P. A., Fruh K., Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15:1996a;3247-3255.
3. Ahn K., Angulo A., Ghazal P., Peterson P. A., Yang Y., Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93:1996b;10990-10994.
4. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J. H. J., Ploegh H. L., Peterson P. A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 1997.
5. Andersson M., Paabo S., Nilsson T., Peterson P. A. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 43:1985;215-222.
6. +. J. Virol. 68:1994;4700.
7. Bertoletti A., Sette A., Chisari F. V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407-410.
8. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen HLA-A2. Nature. 329:1987;506-512.
9. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B. A., Shaw G. M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:1997;205-211.
10. P. Borrow, M. B. A. Oldstone, 1997, Lymphocytic choriomeningitis virus, Viral Pathogenesis, et al. 593, 627, Lippincott-Raven, Philadelphia.
11. Borrow P., Evans C. F., Oldstone M. B. A. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1995;1059-1070.
12. Burgert H.-G., Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell. 41:1985;987-997.
13. Burrows J. M., Burrows S. R., Poulsen L. M., Sculley T. B., Moss D. J., Khanna R. Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: Implications for virus evolution. J. Virol. 70:1996;2490-2496.
14. Couillin I., Connan F., Culmann-Penciolelli B., Gomard E., Guillet J. G., Choppin J. HLA-dependent variants in human immunodeficiency virus NEF protein alter peptide/HLA binding. Eur. J. Immunol. 25:1995;728-732.
15. +. Science. 260:1993;98-100.
16. Driscoll J., Goldberg A. L. The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J. Biol. Chem. 265:1990;4789-4792.
17. Efrat S., Fejer G., Brownlee M., Horwitz M. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc. Natl. Acad. Sci. USA. 92:1995;6947-6951.
18. Eisenlohr L. C., Yewdell J. W., Bennink J. R. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:1992;481-487.
19. Fruh K., Ahn K., Peterson P. A. Inhibition of MHC class I antigen presentation by viral proteins. J. Mol. Med. 1997.
20. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P. M., Tampe R., Peterson P. A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:1995;415-418.
21. Fujinami R. S., Oldstone M. B. A. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature. 279:1979;529-530.
22. Garcia K. C., Degano M., Stanfield R. L., Brunmark A., Jackson M. R., Peterson P. A., Teyton L., Wilson I. A. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
23. Good R. A. Experiments of nature in the development of modern immunology. Immunol. Today. 12:1991;283-286.
24. Goulder P. J. R., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M. A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A. J., Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3:1997;312-317.
25. Guidotti L. G., Ando K., Hobbs M. V., Ishikawa T., Runkel L., Schreiber R. D., Chisari F. V. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;3764-3768.
26. Harrer T., Harrer E., Kalams S. A., Barbosa P., Trocha A., Johnson R. P., Elbeik T., Feinberg M. B., Buchbinder S. P., Walker B. D. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:1996;2616-2623.
27. Henderson R. A., Michel H., Sakaguchi K. HLA2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation. Science. 255:1992;1264-1266.
28. Hill A., Jugovic P., York I., Rus G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
29. A. Hill, M. Kleijnen, D. Schust, U. Koszinowski, H. Ploegh, 1996, Murine cytomegalovirus (MCMV) encodes a 34 kDa glycoprotein which binds to class I MHC molecules at the surface of infected cells, Cell Biology of Virus Entry, Replication and Pathogenesis.
30. Howcroft T., Strebel K., Martin M., Singer D. Repression of MHC class I gene promoter activity by two-exon TAT of HIV. Science. 260:1993;1320.
31. bb. Virology. 1997.
32. b. J. Biol. Chem. 271:1996;17829-17836.
33. Jackson M. R., Nilsson T., Peterson P. A. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9:1990;3153-3162.
34. Jamieson B. D., Ahmed R. T-cell tolerance: Exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc. Natl. Acad. Sci. USA. 85:1988;2265-2268.
35. Joly E., Oldstone M. B. A. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Nature. 8:1992;1185.
36. Joly E., Mucke L., Oldstone M. B. A. Viral persistence in neurons explained by lack of major histocompatibility complex class I expression. Science. 253:1991;1283-1285.
37. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:1995;4830-4841.
38. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Koppe B., Rosenberg W., Boyd D., Edwards A., Giangrande P., Phillips R. E., McMichael A. J. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature. 369:1994;403-407.
39. Koup R. A. Virus escape from CTL recognition. J. Exp. Med. 180:1994;779-782.
40. Levine B., Hardwick J. M., Trapp B. D., Crawford T. O., Bollinger R. C., Griffin D. E. Antibody-mediated clearance of alphavirus infection from neurons. Science. 254:1991;856-860.
41. Levine B., Griffin D. E. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J. Virol. 66:1992;6429-6435.
42. Lewicki H., Tishon A., Borrow P., Evans C. F., Gairin J. E., Hahn K. M., Jewell D. A., Wilson I. A., Oldstone M. B. A. CTL escape viral variants. I. Generation and molecular characterization. Virology. 210:1995a;29-40.
43. Lewicki H. A., von Herrath M. G., Evans C. F., Whitton J. L., Oldstone M. B. A. CTL escape viral variants. II. Biologic activity in vivo. Virology. 211:1995b;433-450.
44. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science. 268:1995;533-539.
45. ++. J. Virol. 68:1994;8056-8063.
46. +. J. Clin. Invest. 94:1994;1947.
47. Moskophidis D., Zinkernagel R. M. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69:1995;2187-2193.
48. ++. Immunobiology. 190:1994;183-194.
49. Nilsson T., Jackson M., Peterson P. A. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell. 58:1989;707-718.
50. Ossendorp F., Eggers M., Neisig A., Ruppert T., Groettrup M., Sijts A., Mengede E., Kloetzel P.-M., Neefjes J., Koszinowski U., Melief C. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:1996;115-124.
51. Pircher H., Moskophidis D., Rohrer U., Burki K., Hengartner H., Zinkernagel R. M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:1990;629-633.
52. +. J. Virol. 70:1996;8165-8168.
53. Rechsteiner M., Hoffman L., Dubiel W. The multicatalytic and 26 S proteases. J. Biol. Chem. 268:1993;6065-6068.
54. +. Proc. Natl. Acad. Sci. USA. 87:1990;6058.
55. Sissons J. G. P., Schreiber R. D., Perrin L. H., Cooper N. R., Muller-Eberhard H. J., Oldstone M. B. A. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody. J. Exp. Med. 150:1979;445-454.
56. Slater J. S., Campbell A. E. Down-regulation of MHC class I synthesis by murine cytomegalovirus occurs in immortalized but not primary fibroblasts. Virology. 229:1997;221-227.
57. Sykulev Y., Joo M., Vturina I., Tsomides T. J., Eisen H. N. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity. 4:1996;565-571.
58. Tahle R., Szepan U., Hengel H., Geginat G., Lucin P., Koszinowski U. H. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69:1995;6098-6105.
59. Thomsen A. R., Johansen J., Marker O., Christensen J. P. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157:1996;3074.
60. Tishon A., Lewicki H., Rall G., von Herrath M., Oldstone M. B. A. An essential role for type 1 interferon-γ in terminating persistent viral infection. Virology. 212:1995;244-250.
61. Townsend A., Trowsdale J. The transporters associated with antigen presentation. Semin. Cell Biol. 4:1993;53-61.
62. +. J. Immunol. 150:1993;2346-2355.
63. von Herrath M. G., Efrat S., Oldstone M. B. A., Horwitz M. Expression of adenoviral E3 transgenes in β-cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. USA, 1997.
64. Whitton J. L., Oldstone M. B. A. Immune response to viruses. Fields B. N. Fields Virology. 1996;345-374 Lippincott-Raven, Philadelphia.
65. Wiertz E. J. H. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the ER to the cytosol. Cell. 84:1996;769-779.
66. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus infected cells: Lysis restricted by HLA-11 MB and DR antigens. J. Immunol. 133:1984;422-427.
67. +. Cell. 77:1994;525-535.